Thymosin β4 from mast cells damages intestinal barrier in IBS through IL22RA1/JAK1/STAT3 signaling | Research

The takeaway

Mast cell-derived thymosin β4 is elevated in IBS mucus and impairs intestinal barrier integrity by inhibiting the IL22RA1/JAK1/STAT3 protective pathway, with Tβ4-knockout rats resistant to stress-induced barrier disruption.

Tβ4 knockout = stress resistance
Rats lacking thymosin β4 were resistant to stress-induced intestinal barrier damage, proving this mast cell peptide is essential for IBS pathogenesis

What the researchers found

High Tβ4 in IBS mucus and mast cells. Tβ4: ↓tight junctions, ↓IL22RA1/Reg3γ, ↑MLCK. Tβ4-/- rats: stress-resistant. CRH receptor 1: triggers Tβ4 release (not degranulation). Mechanism: IL22RA1/JAK1/STAT3 pathway inhibition.

Why it matters

IBS affects 10-15% of the global population with limited understanding of its pathogenesis. Identifying Tβ4 as a specific mediator linking stress, mast cells, and barrier dysfunction provides a targetable mechanism for this common condition.

How the study worked

IBS patient samples. Tβ4-/- rats, Kit w-sh/w-sh (MC-deficient) mice. In vivo stress models. In vitro barrier assays. CRH/Tβ4 release mechanisms. Western blot, immunostaining.

What this study cannot tell us

Animal models may not fully replicate human IBS. Tβ4 measurement in IBS patients was correlative. Therapeutic Tβ4 targeting not yet tested.

How to read the evidence

Comprehensive translational study with human samples, knockout models, and mechanistic pathway dissection. Strong evidence.

When this study was published

Published in 2025.

The bigger picture

This connects three key IBS concepts: stress (via CRH), mast cell activation (via Tβ4 release), and barrier dysfunction (via IL22RA1/STAT3). Targeting Tβ4 could address the root cause of stress-triggered IBS flares.

Questions still open

Could Tβ4 inhibitors treat IBS?
Is Tβ4 a diagnostic biomarker for IBS?
Does Tβ4 contribute to other stress-related GI disorders?

Common questions

How does stress cause IBS symptoms?

This study reveals the mechanism: stress hormones (CRH) trigger mast cells in the gut to release thymosin β4, which then damages the intestinal barrier by suppressing protective signaling (IL22RA1/JAK1/STAT3). This allows bacteria and toxins to pass through the gut wall, causing the pain and discomfort of IBS.

Could blocking thymosin β4 treat IBS?

Potentially. Rats genetically lacking thymosin β4 were completely resistant to stress-induced gut barrier damage. If drugs can be developed to block Tβ4 release from mast cells or its downstream signaling, they could prevent stress-triggered IBS flares at the source.

Read the original research

Thymosin β4 released by mast cells under stress conditions impairs intestinal epithelial barrier via IL22RA1/JAK1/STAT3 signaling in irritable bowel syndrome.

World journal of gastroenterology, 31(42), 111706

View on PubMed ↗Publisher’s paper ↗

Citation

Sun, Yue-Shan; Bai, Xiao-Qin; Sun, Kai-Di; Li, Jiao; Liu, Lei; Chen, Yuan-Yuan; Zeng, Zhao-Yu; Wang, Qiong; Guo, Yuan-Biao. (2025). Thymosin β4 released by mast cells under stress conditions impairs intestinal epithelial barrier via IL22RA1/JAK1/STAT3 signaling in irritable bowel syndrome.. World journal of gastroenterology, 31(42), 111706. https://doi.org/10.3748/wjg.v31.i42.111706